Triathlon Prim Baseplate (Howmedica) – Implant Profile Issue (2021)
The baseplate's internal profile may prevent proper locking of the surgical implant insert.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Triathlon Prim CEM FXD BPLT 7, Catalog No. 5520B700
Brand
Howmedica Osteonics Corp.
Lot Codes / Batch Numbers
Lot JHS2H
Products Sold
Lot JHS2H
Howmedica Osteonics Corp. is recalling Triathlon Prim CEM FXD BPLT 7, Catalog No. 5520B700 due to The internal profile of the Triathlon Prim (Baseplate) is potentially oversized; there may be a witness mark (taper) at the bottom of the internal pro. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The internal profile of the Triathlon Prim (Baseplate) is potentially oversized; there may be a witness mark (taper) at the bottom of the internal profile of the baseplate, which prevents the insert from locking on the baseplate.
Recommended Action
Per FDA guidance
On July 1, 2021, the firm notified customers via Urgent Medical Device Recall. The letter listed the hazards and harms potentially associated with the recalled product and also listed mitigation factors. Patients treated with an affected product should continue to be followed per the normal protocol established by his or her surgeon(s). There are no recommended changes to the frequency of the standard follow-up care protocol. It should be noted that the failure of the insert to fully seat, may not be evident on x-ray unless the insert has dislodged. Actions Needed: Our records indicate that you may have received the affected product(s). It is Strykers responsibility as the manufacturer to ensure that customers who may have received these affected products also receive this important follow up communication. We therefore request that you read this notice carefully and complete the following actions. 1. Please inform users of this Urgent Medical Device Recall and forward this notice to all individuals who need to be made aware. 2. Immediately check all stock areas and/or operating room storage to determine if any devices from the affected product list are at your facility. 3. Quarantine and discontinue use of the recalled devices identified in the affected product list. Return the devices back to Stryker. Customers should complete and sign the included customer response form and return it to the recalling firm. Hospitals should contact their local sales office or Stryker sales representative directly for product returns and inventory questions. Customers who have further distributed the product should forward should notify downstream accounts and return all affected devices to the recalling firm. For questions pertaining to the recall, please contact Customer Service at (201) 831-5000, or email SO_M_PRODUCT_FIELD_ACTION_RESPONSE@stryker.com
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026